ReleaseWire Connect

A deadline is coming up on June 28, 2015 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of Celera Corporation (NASDAQ: CRA) between April 24, 2008 to July 22, 2009.

An investigation on behalf of investors of Weibo Corp (ADR) (NASDAQ:WB) shares over potential securities laws violations by Weibo Corp and certain of its directors and officers in connection certain financial statements was announced.

An investor, who purchased shares of ForceField Energy Inc (NASDAQ:FNRG), filed a lawsuit in the U.S. District Court for the District Court for the Southern District of New York over alleged violations of Federal Securities Laws by ForceField Energy Inc in connection with certain allegedly false and misleading statements made between September 16, 2013 and April 15, 2015.

An investigation on behalf of current long-term investors in shares of Inogen Inc (NASDAQ:INGN) concerning potential breaches of fiduciary duties by certain directors and officers of Inogen Inc was announced.

An investigation on behalf of current long-term investors in shares of Corporate Resource Services Inc (NASDAQ:CRRS) concerning potential breaches of fiduciary duties by certain directors and officers of Corporate Resource Services Inc was announced.

An investigation on behalf of current long-term investors in shares of TCP International Holdings Ltd (NYSE:TCPI) concerning potential breaches of fiduciary duties by certain directors and officers of TCP International Holdings Ltd was announced.

A deadline is coming up on April 27, 2015 in the lawsuit filed for investors of Bridgepoint Education Inc (NYSE:BPI) over alleged violations of Federal Securities Laws by Bridgepoint Education.

An investigation on behalf of investors of AngioDynamics, Inc. (NASDAQ:ANGO) shares over potential securities laws violations by AngioDynamics, Inc. and certain of its directors and officers in connection certain financial statements was announced.

An investigation for investors in shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX) over potential violations of federal securities laws by Pacira Pharmaceuticals Inc (and certain of its directors and officers was announced.

An investigation on behalf of current long-term investors in shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) concerning potential breaches of fiduciary duties by certain directors and officers of Orexigen Therapeutics was announced.